Hair analysis could be the key to understanding adolescent drug usage, as a new study uncovers almost double the number of children were found to be using substances than those who admitted to in a US survey.

Psychostimulants interacting with the dopamine transporter are found in the therapy of neuro-psychiatric disorders, such as ADHD or depression, as well as on the illicit drug market. In order to better understand their exact mode of action and undesirable effects, a research team has been working on the question of why different substances in this group of substances have different effects: According to their results the answer lies in the respective binding time of the substances to the dopamine transporter. This study has just been published in the journal Proceedings of the National Academy of Sciences (PNAS).

Potentially life-saving steroids commonly given to preterm babies also increase the risk of long-term cardiovascular problems, but a new study in rats has found that if given in conjunction with statins, their positive effects remain while the potential negative side-effects are 'weeded out'.

Craving is known to be a key factor in substance use disorders and can increase the likelihood of future drug use or relapse. Yet its neural basis -- or, how the brain gives rise to craving -- is not well understood. In a new study, researchers from have identified a stable brain pattern, or neuromarker, for drug and food craving.

In an effort to identify a more universal treatment for drug overdose, a team of scientists tested a chemical compound -- Pillar[6]MaxQ (P6AS) -- as an antidote for methamphetamine and fentanyl. Their findings were highly promising.

Simultaneous cannabis and alcohol use, defined as using both substances at the same time so their effects overlap, increased in adults from 2008 to 2019, according to new research. Shifts in cannabis legislation have raised questions about unintended effects on cannabis and alcohol use patterns, whereby policy changes might lead people to use both substances. Until now, the relationships between recreational cannabis laws (RCLs) and changes in simultaneous cannabis/alcohol use prevalence had remain untested.

Researchers have modified a yeast cell to sense the active substances in cannabis and get it to turn red when it does. The result paves the way for more actors to discover new medicinal substances and for a new type of drug test that can be done with a smartphone.

A collaboration of scientists found a novel way to render benign the worst side effects of fentanyl.

Scientists have successfully identified the urinary biomarkers of an emerging subclass of synthetic cannabinoids, called OXIZID, to monitor potential abuse.